US Stock MarketDetailed Quotes

BridgeBio Pharma (BBIO)

Watchlist

69.660
+1.050+1.53%

Close May 14 15:59 ET

69.660
0.0000.00%

Post 20:01 ET

13.64BMarket Cap-18.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BridgeBio Pharma (BBIO) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

66.78%194.52M

126.26%502.08M

2,521.18%154.18M

4,318.01%120.7M

4,999.86%110.57M

-44.76%116.63M

2,285.27%221.9M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

Operating revenue

66.78%194.52M

126.26%502.08M

2,521.18%154.18M

4,318.01%120.7M

4,999.86%110.57M

-44.76%116.63M

2,285.27%221.9M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

Cost of revenue

276.62%9.94M

440.54%20.96M

289.01%8.11M

997.49%6.56M

510.87%3.65M

341.30%2.64M

58.54%3.88M

248.49%2.08M

0.00%598K

-0.17%598K

Gross profit

61.92%184.58M

120.67%481.11M

3,746.00%146.07M

5,248.50%114.14M

6,709.68%106.91M

-45.85%113.99M

3,079.58%218.02M

231.12%3.8M

-38.91%2.13M

50.67%1.57M

Operating expense

33.40%290.53M

23.61%983.18M

21.93%274.5M

32.35%250.5M

37.98%240.39M

5.33%217.8M

31.19%795.39M

26.61%225.13M

17.62%189.26M

21.31%174.22M

Selling and administrative expenses

54.09%163.9M

83.86%531.23M

66.79%158.09M

99.98%137.62M

116.98%129.15M

61.63%106.37M

91.87%288.93M

99.19%94.78M

92.36%68.82M

64.78%59.52M

Research and development costs

13.65%126.64M

-10.76%451.95M

-10.69%116.42M

-6.29%112.87M

-3.02%111.23M

-20.96%111.43M

11.14%506.46M

0.10%130.35M

-3.75%120.44M

6.70%114.7M

Operating profit

-2.08%-105.96M

13.04%-502.06M

41.97%-128.43M

27.13%-136.36M

22.69%-133.47M

-2,873.23%-103.8M

3.68%-577.37M

-25.29%-221.33M

-18.87%-187.13M

-21.10%-172.65M

Net non-operating interest income expense

-26.70%-46.57M

-93.06%-158.39M

-82.92%-45.98M

-112.04%-41.91M

-90.16%-33.74M

-89.50%-36.76M

-29.71%-82.04M

-71.12%-25.14M

-19.69%-19.77M

-10.34%-17.74M

Non-operating interest income

15.99%6.25M

15.10%19.85M

-7.50%4.33M

89.29%6.24M

-24.97%3.9M

32.15%5.39M

-4.37%17.25M

-16.05%4.68M

-13.10%3.3M

15.09%5.2M

Non-operating interest expense

25.33%52.82M

79.52%178.24M

68.72%50.31M

108.79%48.15M

64.09%37.64M

79.54%42.14M

22.14%99.29M

47.13%29.82M

13.57%23.06M

11.38%22.94M

Other net income (expense)

51.70%-14.03M

-161.47%-72.05M

-2.92%-20.34M

-119.26%-8.21M

-112.58%-14.45M

-41.66%-29.05M

1,141.16%117.22M

-194.01%-19.76M

867.60%42.64M

5,688.61%114.85M

Gain on sale of security

----

--7M

----

-55.57%8.14M

----

Earnings from equity interest

-17.53%-18.28M

-132.84%-72.61M

-25.96%-21.03M

-141.26%-15.83M

-154.75%-20.19M

---15.56M

---31.18M

---16.7M

---6.56M

---7.93M

Special income (charges)

--0

-131.22%-42.5M

-176.19%-42.37M

-84.51%7.62M

-100.66%-805K

27.56%-21.73M

1,817.46%136.13M

-519.84%-15.34M

985.74%49.2M

3,576.95%122.77M

-Less：Restructuring and merger&acquisition

--0

39.21%21.35M

137.18%11.13M

91.32%8.84M

-72.15%805K

-81.78%570K

93.46%15.33M

522.41%4.69M

1,598.90%4.62M

-18.13%2.89M

-Less:Impairment of capital assets

----

--0

--271K

--0

-Less:Other special charges

----

-20.44%21.16M

--0

----

-20.44%21.16M

--26.59M

--0

----

-Gain on sale of business

----

--0

----

--178.32M

--0

--52.03M

--126.29M

-Gain on sale of property,plant,equipment

----

816.03%16.46M

1,136.08%6.55M

----

134.01%1.8M

---632K

Other non- operating income (expenses)

-48.33%4.25M

250.86%43.06M

----

-196.58%-452K

-13.20%8.23M

-29.35%12.27M

----

515.79%468K

Income before tax

1.80%-166.56M

-35.10%-732.5M

26.85%-194.76M

-13.53%-186.48M

-140.47%-181.66M

-369.05%-169.61M

17.00%-542.19M

-56.31%-266.24M

8.49%-164.25M

52.99%-75.54M

Income tax

-62.27%435K

-110.41%-120K

-1.55M

2.1M

1.15M

Net income

1.80%-166.56M

-34.89%-732.94M

27.21%-194.64M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

16.82%-543.35M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

Net income continuous Operations

1.80%-166.56M

-34.89%-732.94M

27.21%-194.64M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

16.82%-543.35M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

Minority interest income

-14.91%-2.51M

-5.56%-8.01M

24.24%-1.77M

0.90%-2.19M

11.16%-1.86M

-131.57%-2.19M

24.52%-7.59M

-7.29%-2.34M

11.05%-2.21M

25.53%-2.09M

Net income attributable to the parent company

2.02%-164.04M

-35.31%-724.93M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.9M

-375.41%-167.42M

16.70%-535.76M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

2.02%-164.04M

-35.31%-724.93M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.9M

-375.41%-167.42M

16.70%-535.76M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

Basic earnings per share

4.55%-0.84

-31.25%-3.78

28.57%-1

-10.47%-0.95

-143.59%-0.95

-340.00%-0.88

27.09%-2.88

-45.83%-1.4

20.37%-0.86

60.20%-0.39

Diluted earnings per share

4.55%-0.84

-31.25%-3.78

28.57%-1

-10.47%-0.95

-143.59%-0.95

-340.00%-0.88

27.09%-2.88

-45.83%-1.4

20.37%-0.86

60.20%-0.39

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	66.78%194.52M	126.26%502.08M	2,521.18%154.18M	4,318.01%120.7M	4,999.86%110.57M	-44.76%116.63M	2,285.27%221.9M	237.08%5.88M	-33.22%2.73M	32.11%2.17M
Operating revenue	66.78%194.52M	126.26%502.08M	2,521.18%154.18M	4,318.01%120.7M	4,999.86%110.57M	-44.76%116.63M	2,285.27%221.9M	237.08%5.88M	-33.22%2.73M	32.11%2.17M
Cost of revenue	276.62%9.94M	440.54%20.96M	289.01%8.11M	997.49%6.56M	510.87%3.65M	341.30%2.64M	58.54%3.88M	248.49%2.08M	0.00%598K	-0.17%598K
Gross profit	61.92%184.58M	120.67%481.11M	3,746.00%146.07M	5,248.50%114.14M	6,709.68%106.91M	-45.85%113.99M	3,079.58%218.02M	231.12%3.8M	-38.91%2.13M	50.67%1.57M
Operating expense	33.40%290.53M	23.61%983.18M	21.93%274.5M	32.35%250.5M	37.98%240.39M	5.33%217.8M	31.19%795.39M	26.61%225.13M	17.62%189.26M	21.31%174.22M
Selling and administrative expenses	54.09%163.9M	83.86%531.23M	66.79%158.09M	99.98%137.62M	116.98%129.15M	61.63%106.37M	91.87%288.93M	99.19%94.78M	92.36%68.82M	64.78%59.52M
Research and development costs	13.65%126.64M	-10.76%451.95M	-10.69%116.42M	-6.29%112.87M	-3.02%111.23M	-20.96%111.43M	11.14%506.46M	0.10%130.35M	-3.75%120.44M	6.70%114.7M
Operating profit	-2.08%-105.96M	13.04%-502.06M	41.97%-128.43M	27.13%-136.36M	22.69%-133.47M	-2,873.23%-103.8M	3.68%-577.37M	-25.29%-221.33M	-18.87%-187.13M	-21.10%-172.65M
Net non-operating interest income expense	-26.70%-46.57M	-93.06%-158.39M	-82.92%-45.98M	-112.04%-41.91M	-90.16%-33.74M	-89.50%-36.76M	-29.71%-82.04M	-71.12%-25.14M	-19.69%-19.77M	-10.34%-17.74M
Non-operating interest income	15.99%6.25M	15.10%19.85M	-7.50%4.33M	89.29%6.24M	-24.97%3.9M	32.15%5.39M	-4.37%17.25M	-16.05%4.68M	-13.10%3.3M	15.09%5.2M
Non-operating interest expense	25.33%52.82M	79.52%178.24M	68.72%50.31M	108.79%48.15M	64.09%37.64M	79.54%42.14M	22.14%99.29M	47.13%29.82M	13.57%23.06M	11.38%22.94M
Other net income (expense)	51.70%-14.03M	-161.47%-72.05M	-2.92%-20.34M	-119.26%-8.21M	-112.58%-14.45M	-41.66%-29.05M	1,141.16%117.22M	-194.01%-19.76M	867.60%42.64M	5,688.61%114.85M
Gain on sale of security	----	----	----	----	--7M	----	-55.57%8.14M	----	----	----
Earnings from equity interest	-17.53%-18.28M	-132.84%-72.61M	-25.96%-21.03M	-141.26%-15.83M	-154.75%-20.19M	---15.56M	---31.18M	---16.7M	---6.56M	---7.93M
Special income (charges)	--0	-131.22%-42.5M	-176.19%-42.37M	-84.51%7.62M	-100.66%-805K	27.56%-21.73M	1,817.46%136.13M	-519.84%-15.34M	985.74%49.2M	3,576.95%122.77M
-Less：Restructuring and merger&acquisition	--0	39.21%21.35M	137.18%11.13M	91.32%8.84M	-72.15%805K	-81.78%570K	93.46%15.33M	522.41%4.69M	1,598.90%4.62M	-18.13%2.89M
-Less:Impairment of capital assets	----	--0	--0	--0	--0	--0	--271K	--0	--0	--0
-Less:Other special charges	----	-20.44%21.16M	--0	----	----	-20.44%21.16M	--26.59M	--0	----	----
-Gain on sale of business	----	--0	--0	--0	--0	----	--178.32M	--0	--52.03M	--126.29M
-Gain on sale of property,plant,equipment	----	----	----	816.03%16.46M	1,136.08%6.55M	----	----	----	134.01%1.8M	---632K
Other non- operating income (expenses)	-48.33%4.25M	250.86%43.06M	----	----	-196.58%-452K	-13.20%8.23M	-29.35%12.27M	----	----	515.79%468K
Income before tax	1.80%-166.56M	-35.10%-732.5M	26.85%-194.76M	-13.53%-186.48M	-140.47%-181.66M	-369.05%-169.61M	17.00%-542.19M	-56.31%-266.24M	8.49%-164.25M	52.99%-75.54M
Income tax		-62.27%435K	-110.41%-120K	-1.55M	2.1M		1.15M	1.15M	0	0
Net income	1.80%-166.56M	-34.89%-732.94M	27.21%-194.64M	-12.59%-184.94M	-143.25%-183.76M	-369.05%-169.61M	16.82%-543.35M	-56.98%-267.39M	8.49%-164.25M	52.99%-75.54M
Net income continuous Operations	1.80%-166.56M	-34.89%-732.94M	27.21%-194.64M	-12.59%-184.94M	-143.25%-183.76M	-369.05%-169.61M	16.82%-543.35M	-56.98%-267.39M	8.49%-164.25M	52.99%-75.54M
Minority interest income	-14.91%-2.51M	-5.56%-8.01M	24.24%-1.77M	0.90%-2.19M	11.16%-1.86M	-131.57%-2.19M	24.52%-7.59M	-7.29%-2.34M	11.05%-2.21M	25.53%-2.09M
Net income attributable to the parent company	2.02%-164.04M	-35.31%-724.93M	27.24%-192.86M	-12.78%-182.74M	-147.64%-181.9M	-375.41%-167.42M	16.70%-535.76M	-57.63%-265.05M	8.45%-162.04M	53.48%-73.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	2.02%-164.04M	-35.31%-724.93M	27.24%-192.86M	-12.78%-182.74M	-147.64%-181.9M	-375.41%-167.42M	16.70%-535.76M	-57.63%-265.05M	8.45%-162.04M	53.48%-73.46M
Basic earnings per share	4.55%-0.84	-31.25%-3.78	28.57%-1	-10.47%-0.95	-143.59%-0.95	-340.00%-0.88	27.09%-2.88	-45.83%-1.4	20.37%-0.86	60.20%-0.39
Diluted earnings per share	4.55%-0.84	-31.25%-3.78	28.57%-1	-10.47%-0.95	-143.59%-0.95	-340.00%-0.88	27.09%-2.88	-45.83%-1.4	20.37%-0.86	60.20%-0.39
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm